← All Sponsors
SPONSOR

Kartos Therapeutics, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 2, Phase 3
Conditions studied: Endometrial Cancer
NCT05797831 Phase 2, Phase 3
Recruiting

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Endometrial Cancer
United States, Austria, Canada View Trial →